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Abstract
OBJECTIVE: To investigate the effect of Bushenyisui
Formula on cell apoptosis and positive B cell lym-
phoma (Bcl-2) in the Brain of rat models of Alzheim-
er's disease (AD) induced by beta-amyloid protein
(Aβ) and the mechanism underlying the effect.
METHODS: Total of 40 SD rats, 20 females and 20
males, were randomly assigned to 4 groups, con-
trolled group (A), model group (B), conventional
treatment group (C) and Bushenyisui Formula treat-
ment (BYFT) group (D), 10 rats in each group. Aβ
1-42 was injected into the bilateral hippocampus of
the rats in group B, C and D to create the models of
AD. Sham operation was performed on the rats of
group A in the same way by injecting equal volume
of 0.9% sodium chloride solution into their bilateral
hippocampus. 5 days after operation, Bushenyisui
Formula was intraperitoneally administered at a
dose of 450 mg/kg to the rats of group D (QD) for 20
days. Equal volume of 0.9% sodium chloride solution
was intraperitoneally injected into the rats of groupB
with the same procedure. C suspension (20 mg/mL)
was intraperitoneally injected into the rats of group
B with the same procedure. The number of apoptot-
ic cells in Brain and the positive Bcl-2 were count-
ed. The changes of learning and memory abilities
were evaluated using Y-maze.
RESULTS: Right after the establishment of the mod-
els, group B, C and D compared to group A respec-
tively, the outcomes of Y-maze were significantly
different from that of group A, which suggested ob-
vious learning and memory disorder in those
groups (P<0.01). After treatment, the times of elec-
tronic shocks of group C and D were significantly
less than that of group B (P<0.05), and the numbers
of apoptotic cells and positive Bcl-2 were signifi-
cantly different from those of group B, apoptotic
sells' number of group C and D smaller than that of
group B and the number of positive Bcl-2 greater
than that of group B.
CONCLUSION: Bushenyisui Formula could increase
the number of Bcl-2 in brain, which improved the
function of nervous system pertaining to learning
and memory abilities.
© 2012 JTCM. All rights reserved.
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INTRODUCTION
Alzheimer's disease (AD) is a slowly progressive illness
characterized by cognitive, personality and behavioral
changes. The first symptom is recent memory impair-
ment, and then, followed by a series of cognitive dys-
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function including decline in language ability, the loss
of reasoning ability, movement impairment, personali-
ty change, and so forth. The main pathology features
in brain atrophy, deposits of senile plaques and neurofi-
brillary tangles in the brain.1
Due to the complexity of AD's pathogenesis it brings a
great difficulty for its treatment. So seeking a way to
combat it has been a task for medical science that is
not only able to improve the cognitive function of AD
sufferers comprehensively, but also fit for long-term
use with little side effects. Bushenyishui Formula, a Tra-
ditional Chinese Medicine (TCM) treatment, has bidi-
rectional regulation effect on AD without obvious tox-
ic and side effects and caught the attention of medical
professionals.
Recently, quite a few studies have reported on the
mechanism of treating AD with TCM. They mainly fo-
cus on the regulation of central neurotransmitters, anti-
oxidant and anti-neurotoxin properties. However, the
research into TCM treatment of this disease is not yet
systematic and far from comprehensive. Therefore it is
very imperative to exploit advanced molecular biologi-
cal methods, from the perspectives of genomics and
proteomics, to further study TCM's effect on AD.
Focusing on apoptosis, the study compared the ani-
mals' learning and memory abilities before and after
treatment, explored the effect of BuShen YiSui Formu-
la on cell apoptosis and Bcl-2 expression in the rat
models in the hope for providing theory basis for the
treatment of AD.
MATERIALS ANDMETHODS
Animals
Forty purebred SD rats, 300-350 g, half females and
half males, were supplied by the Experimental Animal
Center of Medical School of Xi'an Jiaotong University.
Animal certificate No. is 08-005.
Reagents
Bcl-2 detection kit was purchased from Beijing Zhong-
shan Biological Technology Limited Company. Apopto-
sis detection kit was purchased from Beijing Zhong-
shan Biological Technology Limited Company.
Main instrument
Stans equidistant-radial-arm Y-maze was supplied by
the Department of Pharmacology of Shaanxi Universi-
ty of Chinese Medicine; C-type stereotaxic instrument
was supplied by Huaibei Zhenghua biological equip-
ment limited company. The TL-2000MM-III mi-
cro-oscillator was supplied by Jiangsu Jiangyan Tianli
Medical Instrument Limited Company. E200 Nikon
microscope was supplied by Nikon Nanjing Jiangnan
Optical Instrument Company Limited. Small tank was
supplied by Beijing Medical Equipment Factory.
GTK-2002 automatic thermostat was supplied by
Xi'an Ruifeng Equipment Company.
Animal grouping and model creating
Forty purebred SD rats were fed for three days for adapt-
ability purpose, males and females separated in different
cages with natural light, drinking and eating freely.
Then they were randomly divided into four groups, 10
for each. They were control group A, model group B,
conventional treatment group C and BYFT group D.
Each rat of group B, C and D group, after anesthetized
with 10% chloral hydrate (0.5 mg/kg), was placed on
stereotaxic instrument, then the anterior fontanelle lo-
cated and then skin covering it was cut open. Further,
by referring to rat anatomy atlas, the hippocampus'
projecture on body surface was located at 3.0 mm
away behind anterior fontanelle and at 2.0 mm away
from the rat body's midline. A dental drill was used to
drill a hole into the skull, then a micro-syringe was
pinned on the stereotaxic apparatus and needled to the
depth of about 2.8 mm, then 10 ug/5 uL of Aβ1 -42
solution (fiber type) was slowly injected into the skull
and let the needle stay for 5 min after finishing the in-
jection, then slowly removed the syringe. The rats of
group A underwent the same operation except for in-
jecting 5 uL of saline.
Treatments of the rats
Treatments started on the fifth day after the operations
mentioned above. The rates of group A and B were
kept in separate cages with natural light and freely ac-
cessed to water without any other special treatments.
In group C, piracetam (lot number: 031203; Shanghai
Huashi Pharmaceutical limited company) was used to
prepare the suspension of 20 mg/mL with warm boiled
water. Each rat was intragastrically administered the
suspension with the dose of 450 mg/kg per day (about
2 mL for each rat) group D (QD) for 20 days.
In group D, each rat was intragastrically administered
the decoction of Bushenyisui Formula with the dose of
450 mg/kg per day QD for 20 days. The prescription
of the formulas was: rhizoma Ligustici wallichii 10 g,
notoginseng 10 g, saffron 10 g, turmeric 10 g, rhizoma
gastrodiae 10 g, leeches 10 g, dried tangerine peel 10 g,
rhizoma acori tatarinowii 10 g, salvia 20g, astragalus
30 g, atractylodes 15 g, rhubarb 6 g, amomum 6 g.
Data collection
Y-maze test was conduced for all rats in group A, B, C
and D at one day before the model-creating operation,
the fifth day after the operation, and at the day after
treatments finished. After the tests,, the rats were fasted
for 12 hours, and then specimens and other data were
collected.
Y-maze test: Equidistant-radial-arm Y-maze was used
to measure space learning and memory abilities of the
rats. They had two min to adapt to the environment of
Y-maze. One arm was chosen as starting point where
electric shock was given to the rats staying there
(30-50V, 0.5-0.7mA, delayed for 10 s) to make them
escape to a safe area. After one-min break, the process
was repeated. Counts of which they were electrically
shocked were recorded. 9 out of 10 times that they
made correct responses meant that they had learned
the lesson. The counts were used to evaluate their learn-
ing and memory abilities.
Specimen obtaining: 3% pentobarbital solution (30 mg/
kg) was intraperitoneally administered for anesthesia
purpose, then cardiac perfusion was performed, brain
tissue striped, and slice was cut from the coronal sec-
tion of hippocampus and fixed with 4% paraformalde-
hyde phosphate buffer and water was eluted with gradi-
en ethanol, then it was clarified with xylene. Finally it
was conventionally embedded with paraffin wax.
Bcl-2 and cell apoptosis detection: 1) Immunohisto-
chemistry ABC method for Bcl-2. Making paraffin sec-
tion of paraffin-embedded slice and washing it in 0.01
Midkine Phosphate Buffer Solution (MKPBS) three
times, 5 min each time. Adding 0.3% solution of hy-
drogen peroxide in methanol (methanol 80 mL+0.01
MKPBS 100 mL+30% hydrogen peroxide) and soak-
ing them for 30 min to eliminate the effect of the en-
dogenous peroxidase, then washing them in 0.01MK-
PBS again three times, 5 min each time.
Adding 0.3% Triton ×100 (polyethylene glycol octyl-
phenyl ether) and soaking it for 30 min, to increase
cell permeability, and washing it in 0.01MKPBS once
more three times, 5 min each time.
Adding serum dilution (1 g rat serum albumin +
0.01MKPBS 100 mL+0.08 g sodium azide) to primary
antibody, storing the diluted primary antibody at tem-
perature of 4℃ for 24-48 h, absorbing the antibody,
and then washing it in 0.01 MKPBS again three times,
5 min each time.
Adding 0.01MKPBS to the diluted second antibody, in-
cubating it at room temperature for 2 h, then washing it
in 0.01MKPBS three times, 5 min each time.
Adding rat tumor necrosis factor complex antibody and
incubating it at room temperature for 2 h, then washing
it with 0.01 MKPBS three times, 5 min each time, and
then washing it with distilled quickly three times;
Adding color development solution for immunohisto-
chemical staining, once the cells were stained and the
color of cell background became lighter, eliminating
the color development solution immediately, and wash-
ing it quickly with distilled water three times, then add-
ing 0.01MKPBS to terminate further reaction.
After dehydrating it with gradient alcohol, sealing it
and viewing it with microscope and record the results.
2) Apoptosis TUNEL assay: Placing the tissue slice in
staining jar, washing it twice with xylene, 5 min each
time, then washing it twice with anhydrous ethanol,
3 min each time; washing it with 95% ethanol and
75% ethanol respectively, 3 min each time; washing it
with phosphoric buffer solution (PBS) for 5 min, then
adding proteinase K solution (20 ug/mL) and letting it
be hydrolyzed at room temperature for 15 min, then re-
moving histone; washing it with distilled water 4
times, 2 min each time.
Adding 2% PBS containing hydrogen peroxide into
the staining jar, letting them to react at room tempera-
ture for 5 min; washing the slice twice with PBS, 5 min
each time.
Absorbing with filter paper the excess liquid surround-
ing the slice; adding immediately 2 drops of terminal
deoxynucleotidyl transferase (TDT) buffer, and letting
it to stand at room temperature for 5 min.
Again absorbing with filter paper the extra liquid sur-
rounding the slice; adding immediately 54 uL TDT re-
action mixture and putting it in a humidified chamber
at 37℃ for 1h for reaction.
Placing it in staining jar and adding reaction termina-
tion buffer preheated to 37℃ for washing purpose;
keeping the temperature of 37℃ for 30 min, moving
the slice up and down every 10 min so as to gently stir
the liquid.
Washing it 3 times with PBS, 5 min each time, then
adding two drops of peroxidase-labeled anti-digoxin anti-
body and placing it into humidified chamber for 30 min
for reaction.
Washing it with PBS 4 times, 5 min each time, then
adding the freshly prepared 0.05% diaminobenzidine
(DAB) solution and letting it to be stained at room
temperature for 3 min-6 min.
Washing it with distilled water 4 times, 1 min each
time for the first three times, 5 min for the fourth time.
Restaining it with methyl chloride at room tempera-
ture for 10 min.
Washing it with distilled water 3 times, 1 min each
time. For the first two times after washing it, moving
the slide up and down for 10 times; for the last time af-
ter washing it, letting it stand still for 30 s; then wash-
ing it three more times using 100% N-Butanol with
the same procedure. Dehydrating it three times with
xylene, 2 min each time, then sealing the slice. After
drying it, viewing it with microscope and recording ex-
perimental outcome.
Statistical analysis
SPSS 13.0 was used for data analysis. T-tests were per-
formed to compare group difference, P<0.05 was the
significant level.
RESULTS
Y-maze test results
The Y-maze test results are showed in Table 1. The
means±SDs were summarized from the times they re-
quired for practice until they attain the goal that 9 out
of 10 times they would escape to a safe area without be-
ing electrically shocked.
The detection of cell apoptosis and positive Bcl-2
The counts of apoptotic cells and positive Bcl-2 are
shown in Table 2.
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was repeated. Counts of which they were electrically
shocked were recorded. 9 out of 10 times that they
made correct responses meant that they had learned
the lesson. The counts were used to evaluate their learn-
ing and memory abilities.
Specimen obtaining: 3% pentobarbital solution (30 mg/
kg) was intraperitoneally administered for anesthesia
purpose, then cardiac perfusion was performed, brain
tissue striped, and slice was cut from the coronal sec-
tion of hippocampus and fixed with 4% paraformalde-
hyde phosphate buffer and water was eluted with gradi-
en ethanol, then it was clarified with xylene. Finally it
was conventionally embedded with paraffin wax.
Bcl-2 and cell apoptosis detection: 1) Immunohisto-
chemistry ABC method for Bcl-2. Making paraffin sec-
tion of paraffin-embedded slice and washing it in 0.01
Midkine Phosphate Buffer Solution (MKPBS) three
times, 5 min each time. Adding 0.3% solution of hy-
drogen peroxide in methanol (methanol 80 mL+0.01
MKPBS 100 mL+30% hydrogen peroxide) and soak-
ing them for 30 min to eliminate the effect of the en-
dogenous peroxidase, then washing them in 0.01MK-
PBS again three times, 5 min each time.
Adding 0.3% Triton ×100 (polyethylene glycol octyl-
phenyl ether) and soaking it for 30 min, to increase
cell permeability, and washing it in 0.01MKPBS once
more three times, 5 min each time.
Adding serum dilution (1 g rat serum albumin +
0.01MKPBS 100 mL+0.08 g sodium azide) to primary
antibody, storing the diluted primary antibody at tem-
perature of 4℃ for 24-48 h, absorbing the antibody,
and then washing it in 0.01 MKPBS again three times,
5 min each time.
Adding 0.01MKPBS to the diluted second antibody, in-
cubating it at room temperature for 2 h, then washing it
in 0.01MKPBS three times, 5 min each time.
Adding rat tumor necrosis factor complex antibody and
incubating it at room temperature for 2 h, then washing
it with 0.01 MKPBS three times, 5 min each time, and
then washing it with distilled quickly three times;
Adding color development solution for immunohisto-
chemical staining, once the cells were stained and the
color of cell background became lighter, eliminating
the color development solution immediately, and wash-
ing it quickly with distilled water three times, then add-
ing 0.01MKPBS to terminate further reaction.
After dehydrating it with gradient alcohol, sealing it
and viewing it with microscope and record the results.
2) Apoptosis TUNEL assay: Placing the tissue slice in
staining jar, washing it twice with xylene, 5 min each
time, then washing it twice with anhydrous ethanol,
3 min each time; washing it with 95% ethanol and
75% ethanol respectively, 3 min each time; washing it
with phosphoric buffer solution (PBS) for 5 min, then
adding proteinase K solution (20 ug/mL) and letting it
be hydrolyzed at room temperature for 15 min, then re-
moving histone; washing it with distilled water 4
times, 2 min each time.
Adding 2% PBS containing hydrogen peroxide into
the staining jar, letting them to react at room tempera-
ture for 5 min; washing the slice twice with PBS, 5 min
each time.
Absorbing with filter paper the excess liquid surround-
ing the slice; adding immediately 2 drops of terminal
deoxynucleotidyl transferase (TDT) buffer, and letting
it to stand at room temperature for 5 min.
Again absorbing with filter paper the extra liquid sur-
rounding the slice; adding immediately 54 uL TDT re-
action mixture and putting it in a humidified chamber
at 37℃ for 1h for reaction.
Placing it in staining jar and adding reaction termina-
tion buffer preheated to 37℃ for washing purpose;
keeping the temperature of 37℃ for 30 min, moving
the slice up and down every 10 min so as to gently stir
the liquid.
Washing it 3 times with PBS, 5 min each time, then
adding two drops of peroxidase-labeled anti-digoxin anti-
body and placing it into humidified chamber for 30 min
for reaction.
Washing it with PBS 4 times, 5 min each time, then
adding the freshly prepared 0.05% diaminobenzidine
(DAB) solution and letting it to be stained at room
temperature for 3 min-6 min.
Washing it with distilled water 4 times, 1 min each
time for the first three times, 5 min for the fourth time.
Restaining it with methyl chloride at room tempera-
ture for 10 min.
Washing it with distilled water 3 times, 1 min each
time. For the first two times after washing it, moving
the slide up and down for 10 times; for the last time af-
ter washing it, letting it stand still for 30 s; then wash-
ing it three more times using 100% N-Butanol with
the same procedure. Dehydrating it three times with
xylene, 2 min each time, then sealing the slice. After
drying it, viewing it with microscope and recording ex-
perimental outcome.
Statistical analysis
SPSS 13.0 was used for data analysis. T-tests were per-
formed to compare group difference, P<0.05 was the
significant level.
RESULTS
Y-maze test results
The Y-maze test results are showed in Table 1. The
means±SDs were summarized from the times they re-
quired for practice until they attain the goal that 9 out
of 10 times they would escape to a safe area without be-
ing electrically shocked.
The detection of cell apoptosis and positive Bcl-2
The counts of apoptotic cells and positive Bcl-2 are
shown in Table 2.
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DISCUSSION
The application of transgenic technology recent years
in the research work of animal models of AD strongly
supports the theory that AD is caused by Aβ.2 There
were more reports on AD model induced by injecting
Aβ into hippocampus at home and abroad.3 It was a
practical choice for the research into AD. Recent stud-
ies showed that apoptosis was one of the important
causes that decreased the number of neurons in brain
tissue of AD.3 Apoptosis is controlled by genes and the
process is the result of direct signal transduction.4
The pharmacological effect of piracetam improves the
disturbance of consciousness caused by traumatic brain
injury, stroke, encephalitis, poisoning, and improves
learning and memory ability, and chronic brain dys-
function syndrome, the symptoms of symptomatic psy-
chosis, psychogenic symptoms and extrapyramidal
symptoms induced by medicines etc. It was widely
used as a conventional treatment in cerebrovascular dis-
eases. The use of piracetam can largely catch up with re-
cent clinical practice.5
There is no name of AD in ancient medicine, but de-
mentia was discussed as early as 2000 years ago in
some literature such as Tao Chuan and Huang Pu Mi's
Zhenjiu Jiayi Jing. I believe that, from the perspective
of TCM, AD's etiology and pathogenesis are complicat-
edly associated with the imbalance of Yin and Yang, Qi
and blood, and Zangfus' function. Mostly it is due to
ageing, which causes the deficiency of Zangfus' Qi and
blood. Although the disease locates in the brain, it is re-
lated to heart, liver, spleen and kidney. Of them the
weakness of kidney function which causes the dysfunc-
tion of brain is AD's fundamental pathogenesis. To
sum up, the AD pathogenesis, in terms of TCM theo-
ry, can be describe as deficiency is the root cause while
excess pattern is manifested. The deficiency results
from aging that leads to the deficiency of Qi, blood,
Yin and Yang and the deficiency of several Zangfu or-
gans. Of the deficient organs, kidney is the most defi-
cient one. The combined conditions cause the incapa-
bility to produce enough Qi, boold and essence etc to
nurture the brain, then its marrow becomes deficient,
thus the original spirit of life lacks nourishment, the
bright spirit becomes blunt. Phlegm and blood stasis
are the pathological products of Zangfu organs' defi-
ciency. Due to the deficiency of heart liver, spleen and
kidney, the distribution of Qi, blood and body fluids is
disordered, thus phlegm and blood stasis generated
from inside block the meridians and collateral vessels,
and blunt the brain, thus mental confusing ensues.
In the formula, rhizoma Ligustici can reduce concentra-
tion of platelet thromboxane A2 and raise the level of
prostaglandins while inhibiting vascular smooth mus-
cle contraction, increase blood flow of cerebral arter-
ies.6 Salvia has the effect of inhibiting the aggregation
of thrombus and blood clogs, and significantly dilating
microvascular vessels, and scavenging oxygen free radi-
cals, blocking calcium channels, regulating the hemato-
crit, and so forth. Leech contains hirudin, heparin, an-
ti-thromboxane. 7 It can dilate blood vessels, promote
blood circulation, and inhibit the effect of thrombin
on fibrinogen increase high-density lipoprotein as
well.8 Rhubarb can shorten the time of blood coagula-
tion, reduce capillary permeability for fibrinogen, and
improve lipid metabolism disorder.9-10 Modern pharma-
cological study11-18 also showed that astragalus, notogin-
seng, rhizome gastrodia, saffron, turmeric, radix cur-
cumae and rhizoma acori Tatarinowii had the effects of
anti-free radical damage, anticoagulant, anti-platelet ag-
gregation, promoting fibrinolysis, dilating blood vessels
etc and that angerine peel, amomum and atractylodes
could transport nutrition and control the blood. All
the medicinal combined are able to move and activate
Qi and blood, and dispel stasis. Therefore, from either
TCM or modern medicine's perspective, the formula
has significant effect on dementias of aging population.
In this study, we can see that the number of positive
Bcl-2 increased and the number of apoptotic neuronal
cells decreased both in group C and D, and learning
and memory abilities in the two groups were better
than that of group B as well. These suggest that BuSh-
en YiSui Formula and piracetam are able to treat AD
Time
Before operation
After operation
After treatment
Group A
15.5±2.4
15.0±2.5
14.8±32.0
Group B
15.0±2.5
26.1±6.7a
23.0±4.9
Group C
16.0±3.1
25.2±4.0a
19.0±2.8b
Group D
17.3±21.0
23.3±5.8a
19.3±3.8b
Table 1 The outcomes of Y-maze test (frequency, xˉ ±s)
Notes: a: Group B, C and D were compared with group A respectively. P values were all smaller than 0.01 (PB vs A=0.0001, PA vs C=0.0001, PD
vs A=0.0001); b: after treatment, group C and D were compared with group B respectively. P<0.05 (PB vs C=0.0365, PB vs D=0.0182).
Apoptosis
Bcl-2
Group B
9.8±2.7
10.2±1.5
Group C
7.2±2.3a
11.8±17.0b
Group D
7.2±14.0a
12.64±1.2cd
Table 2 The outcomes of apoptotic cells and positive Bcl-2
detection ( xˉ ±s)
Notes: a: group C and D were compared with group B
respectively, P values were all smaller than 0.05 (PB vs C=0.0309,
PB vs D=0.0157); b:group C was compared with group B. P<0.05
(PB vs C=0.0197); c: group B was compared with group D. P<0.05
(PB vs D=0.0009); d: group C was compared with group D. P>
0.05 (PD vs C=0.1838).
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by improving AD's declined learn and memory abili-
ties to some extent. However, in this study, the effect
of Bushenyisui Formula on increasing positive Bcl-2
and reducing number of apoptotic neuronal cells were
not significant different from those of piracetam. The
study revealed that Bushenyisui Formula worked on
both cell apoptosis and Bcl-2. The mechanism might
be that the formula has effect on these two pathways or
on an interactive pathway between them. Further
study is required to further explore the mechanism un-
derlying the formula treating AD.
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